High-purity enrichment of functional cardiovascular cells from human iPS cells

Cardiovascular Research

Volumn 95, Issue 3, 2012, Pages 327-335

  Lin, Bo ^a   Kim, Jong ^b   Li, Yanxin ^b,c   Pan, Haiying ^d   Carvajal Vergara, Xonia ^e   Salama, Guy ^b   Cheng, Tao ^b,c   Li, Yong ^d   Lo, Cecilia W ^a   Yang, Lei ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^d UT Houston   (United States)

^e CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Cardiovascular cells; Differentiation; Embryonic stem cells; Induced pluripotent stem cells

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC ASSOCIATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LEOPARD SYNDROME; MOUSE; MULTIPOTENT STEM CELL; NEWBORN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOOTH MUSCLE FIBER; UPREGULATION; ANIMAL; CARDIOMEGALY; CELL CULTURE; CELL LINEAGE; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METABOLISM; METHODOLOGY; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; REPRODUCIBILITY; TIME;

ALCAM PROTEIN, HUMAN; BIOLOGICAL MARKER; FETOPROTEIN; LEUKOCYTE ANTIGEN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE;

ANIMALS; ANTIGENS, CD; BIOLOGICAL MARKERS; CARDIOMEGALY; CELL ADHESION MOLECULES, NEURONAL; CELL DIFFERENTIATION; CELL LINEAGE; CELL SEPARATION; CELLS, CULTURED; FETAL PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LEOPARD SYNDROME; MICE; MICE, INBRED NOD; MICE, SCID; MULTIPOTENT STEM CELLS; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TIME FACTORS;

EID: 84865270424     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs185     Document Type: Article

References (37)

1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131: 861-872. (Pubitemid 350138099)
2. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318:917-920.
3. + embryonic-stem-cell- derived population. Nature 2008;453:524-528. (Pubitemid 351733312)
4. Carvajal-Vergara X, Sevilla A, D'Souza S, Ang Y, Schaniel C, Lee DF et al. Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome. Nature 2010;465:808-812.
5. Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A et al. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 2011;6:1-16.
6. Matsa E, Rajamohan D, Dick E, Young L, Mellor I, Staniforth A et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur Heart J 2011;32:952-962.
7. Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A et al. Modeling the long QT syndrome with induced pluripotent stem cells. Nature 2011;471: 225-229.
8. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011;8:228-240.
9. Levenberg S, Zoldan J, Basevitch Y, Langer R. Endothelial potential of human embryonic stem cells. Blood 2007;110:806-814. (Pubitemid 47267415)
10. Li ZJ, Han ZC, Wui JC. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases. J Cell Biochem 2009;106:194-199.
11. Vo E, Hanjaya-Putra D, Zha Y, Kusuma S, Gerecht S. Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro. Stem Cell Rev 2010;2:237-247.
12. Lee TH, Song SH, Kim KL, Yi JY, Shin GH, Kim JY et al. Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ Res 2010;106:120-128.
13. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002;91:501-508.
14. Huber I, Itzhaki I, Caspi O, Arbel G, Tzukerman M, Gepstein A et al. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J 2007;21:2551-2563. (Pubitemid 47230684)
15. Hattori F, Chen H, Yamashita H, Tohyama S, Satoh YS, Yuasa S et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 2010;7:61-66.
16. Dubois N, Craft A, Sharma P, Elliott D, Stanley E, Elefanty A et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 2011;29:1011-1018.
17. Rust W, Balakrishnan T, Zweigerdt R. Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression. Regen Med 2009;4:225-237.
18. Jason X, Yuan J, Rubin L. Pathogenesis of pulmonary arterial hypertension. Circulation 2005;111:534-538.
19. Yang L, Cai CL, Lin L, Qyang Y, Chung C, Evans S. Isl1Cre reveals a common Bmp pathway in heart and limb development. Development 2006;133:1575-1585. (Pubitemid 43732970)
20. Lints T, Parsons L, Hartley L, Lyons I, Harvey R. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 1993;119:419-431. (Pubitemid 23293185)
21. Huang C, Sheikh F, Hollander M, Cai C, Becker D, Chu P et al. Embryonic atrial function is essential for mouse embryogenesis, cardiac morphogenesis and angiogenesis. Development 2003;130:6111-6119. (Pubitemid 38008812)
22. He W, Jia Y, Takimoto K. Interaction between transcription factors Iroquois proteins 4 and 5 controls cardiac potassium channel Kv4.2 gene transcription. Cardiovasc Res 2009;81:64-71.
23. Hirata H, Murakami Y, Miyamoto Y, Tosaka M, Inoue K, Nagahashi A et al. ALCAM (CD166) is a surface marker for early murine cardiomyocytes. Cells Tissues Organs 2006;184:172-180. (Pubitemid 46558937)
24. Kaufman DS, Lewis RL, Hanson ET, Auerbach R, Plendl J, Thomson JA. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood 2004; 103:1325-1332. (Pubitemid 38168644)
25. 2+ triggers early afterdepolarizations and Torsade de Pointes in rabbit hearts with type 2 long QT syndrome. J Physiol 2002;543: 615-631. (Pubitemid 35012214)
26. + current in human ventricular myocytes. Circ Res 1996;78:689-696. (Pubitemid 26106881)
27. + channel. Circ Res 1996;78: 499-503.
28. Braam SR, Tertoolen L, van de Stolpe A, Meyer T, Passier R, Mummery CL. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 2010;4:107-116.
29. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras S et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015-1024. (Pubitemid 47517637)
30. Burns FR, Kannen SV, Guy L, Raper JA, Kamholz J, Chang S. DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension. Neuron 1991;7:209-220.
31. Gesserta S, Maurusa D, Bradea T, Waltherc P, Pandura P, Kühla M. DM-GRASP/ALCAM/CD166 is required for cardiac morphogenesis and maintenance of cardiac identity in first heart field derived cells. Dev Biol 2008;321:150-161.
32. Murakami Y, Hirata H, Miyamoto Y, Nagahashi A, Sawa Y, Jakt M et al. Isolation of cardiac cells from E8.5 yolk sac by ALCAM (CD166) expression. Mech Dev 2007; 124:830-839. (Pubitemid 350051376)
33. Ohneda O, Ohneda K, Arai F, Lee J, Miyamoto T, Fukushima Y et al. ALCAM (CD166): its role in hematopoietic and endothelial development. Blood 2001;98: 2134-2142.
34. Ema M, Faloon P, Zhang WJ, Hirashima M, Reid T, Stanford W et al. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev 2003;17:380-393. (Pubitemid 36182197)
35. Gouon-Evans V, Boussemart L, Gadue P, Nierhoff D, Koehler C, Kubo A et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 2006;24:1402-1411. (Pubitemid 44722104)
36. Marin TM, Keith K, Davies B, Conner DA, Guha P, Kalaitzidis D et al. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest 2011;121:1026-1043.
37. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-b1, fibronectin, and collagen. Am J Physiol 1992;262:H1861-H1866.